Sanford Health
5
11M
4
0.04
1
0.20
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Fargo.
Among the most popular portfolio startups of the fund, we may highlight TytoCare, InGeneron. Among the most popular fund investment industries, there are Biotechnology, Information Technology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups.
The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Sanford Health, startups are often financed by Walgreens, OrbiMed, LionBird. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, Ping An Global Voyager Fund, ITOCHU Corporation.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Rounds per year
- 0.04
- Follow on index
- 0.20
- Investments by industry
- Health Care (4)
- Biotechnology (4)
- Health Diagnostics (3)
- Alternative Medicine (2)
- Therapeutics (2) Show 10 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 92M
- Group Appearance index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Polaris Genomics | 14 Feb 2020 | Biotechnology, Health Diagnostics, Life Science, Pharmaceutical, Clinical Trials | Seed | 2M | United States, Maryland, Rockville |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.